Announcing a NEW Research Study at the Massachusetts General Hospital Center for Women’s Mental Health:
If you are a pregnant woman between the ages of 18 and 45 and currently treated with one or more of the following atypical antipsychotics:
- Abilify (aripiprazole)
- Clozaril (clozapine)
- Geodon (ziprasidone)
- Invega (paliperidone)
- Risperdal (risperidone)
- Seroquel (quetiapine)
- Zyprexa (olanzapine)
Register now by calling 1-866-961-2388 and help us learn more about the safety of these medicines in pregnancy.
This study will involve 3 brief phone interviews over approximately 8-months.
The National Pregnancy Registry for Atypical Antipsychotics was developed to obtain information about the safety of atypical (second generation) antipsychotic medications when used during pregnancy. The primary goal of this Registry is to determine the frequency of major malformations seen after use of atypical antipsychotics during pregnancy compared to what is seen among women who do not take such medications during pregnancy.
For more information about the Registry, please call 1-866-961-2388
